Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,150 | 152 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $515.46 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $335.04 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $211.83 | 14 | $0 (2024) |
| Amgen Inc. | $154.17 | 8 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $121.97 | 14 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.89 | 6 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $85.08 | 5 | $0 (2023) |
| Merck Sharp & Dohme LLC | $81.67 | 4 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $77.95 | 5 | $0 (2024) |
| Edwards Lifesciences Corporation | $70.60 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $653.21 | 33 | AstraZeneca Pharmaceuticals LP ($133.81) |
| 2023 | $998.58 | 73 | Celgene Corporation ($278.87) |
| 2022 | $377.94 | 35 | Celgene Corporation ($182.06) |
| 2021 | $119.98 | 11 | Abbott Laboratories ($52.85) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.57 | General |
| Category: Cardiovascular | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.43 | General |
| Category: Cardiovascular | ||||||
| 08/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Inflammation | ||||||
| 08/19/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 08/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Obesity | ||||||
| 07/31/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Cardiology | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Transcatheter Heart Valves | ||||||
| 06/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Genetic Disease | ||||||
| 06/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Cardiology | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | Celgene Corporation | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: Cardiovascular | ||||||
| 04/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/15/2024 | Celgene Corporation | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.23 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 516 | 557 | $134,993 | $32,881 |
| 2022 | 4 | 550 | 594 | $134,457 | $30,881 |
| 2021 | 4 | 572 | 626 | $124,411 | $32,033 |
| 2020 | 7 | 694 | 761 | $155,029 | $33,674 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 398 | 437 | $121,486 | $29,630 | 24.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 38 | 39 | $6,167 | $1,840 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 23 | $4,324 | $979.10 | 22.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 57 | 58 | $3,016 | $431.68 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 318 | 358 | $99,524 | $23,900 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 133 | 135 | $25,380 | $4,919 | 19.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 41 | 41 | $6,433 | $1,656 | 25.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 58 | 60 | $3,120 | $406.44 | 13.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 290 | 312 | $58,656 | $14,774 | 25.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 176 | 197 | $54,766 | $14,717 | 26.9% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2021 | 42 | 45 | $7,245 | $1,971 | 27.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 64 | 72 | $3,744 | $571.26 | 15.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 296 | 343 | $95,354 | $20,859 | 21.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 197 | 211 | $39,668 | $8,943 | 22.5% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2020 | 57 | 61 | $9,765 | $2,493 | 25.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 54 | 56 | $2,912 | $580.66 | 19.9% |
| 93296 | Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days | Office | 2020 | 40 | 40 | $3,520 | $374.76 | 10.6% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Office | 2020 | 37 | 37 | $3,404 | $316.03 | 9.3% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 13 | 13 | $405.60 | $106.70 | 26.3% |
About Craig Peck, A.R.N.P
Craig Peck, A.R.N.P is a Adult Health healthcare provider based in Springfield, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811996176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Craig Peck, A.R.N.P has received a total of $2,150 in payments from pharmaceutical and medical device companies, with $653.21 received in 2024. These payments were reported across 152 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,150).
As a Medicare-enrolled provider, Peck has provided services to 2,332 Medicare beneficiaries, totaling 2,538 services with total Medicare billing of $129,468. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Springfield, OR
- Active Since 07/19/2005
- Last Updated 11/17/2009
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1811996176
Products in Payments
- ELIQUIS (Drug) $598.34
- FARXIGA (Drug) $264.81
- Repatha (Biological) $139.66
- LifeVest (Device) $121.97
- JARDIANCE (Drug) $121.89
- LEQVIO (Drug) $115.94
- ENTRESTO (Drug) $95.89
- Inpefa (Drug) $85.08
- AMVUTTRA (Drug) $77.95
- XARELTO (Drug) $53.28
- LOKELMA (Drug) $52.48
- VERQUVO (Drug) $44.50
- Wegovy (Drug) $32.73
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $30.68
- MitraClip System (Device) $25.67
- TELEPATCH CARDIAC MONITOR (Device) $24.09
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $22.90
- CAMZYOS (Drug) $18.30
- LINQ II (Device) $18.22
- Ozempic (Drug) $18.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Springfield
Andrea Bushnell, Agnp-C, AGNP-C
Adult Health — Payments: $12,450
Mrs. Kimberly Koval, Rn, Msn, Apn-C, RN, MSN, APN-C
Adult Health — Payments: $11,360
Heidi Crull, Anp-Bc, ANP-BC
Adult Health — Payments: $7,347
Mrs. Jennifer Chieppa, Np-C, NP-C
Adult Health — Payments: $4,961
Marlene Schmitz
Adult Health — Payments: $3,503
Marcy Bot-Baron, Anp, ANP
Adult Health — Payments: $3,493